Allergy Therapeutics plc AGYTF
0.15 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.15 Day range 0.15
0.11 52-week range 0.15
- YTD
- +36.36%
- 1 year
- +36.36%
News
proactiveinvestors.com Boston Scientific beats second quarter expectations, raises full-year outlook Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...
proactiveinvestors.com Allergy Therapeutics reports accelerated revenue growth in its second half Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further...
proactiveinvestors.co.uk Allergy Therapeutics reports accelerated revenue growth in its second half Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further step-up in the current year as Grassmuno enters…
proactiveinvestors.com Allergy Therapeutics names Helge Weiner-Trapness as executive chair Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology...
proactiveinvestors.co.uk Allergy Therapeutics names Helge Weiner-Trapness as executive chair Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology group explores a potential dual primary…
proactiveinvestors.com FTSE 100 Live: London stocks surge, Wall St volatile as SpaceX trading nears FTSE 100 jumps 162 points to 10,466 Brent crude futures fall then rise UK economy contracts 0.1% in April Housebuilders show strong recovery 4.17pm:...
proactiveinvestors.co.uk Allergy Therapeutics to showcase pollen and food allergy progress Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) said it will use Europe's flagship allergy and clinical immunology congress to showcase progress across its pollen and food allergy pipeline,…
proactiveinvestors.com Allergy Therapeutics to showcase pollen and food allergy progress Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) said it will use Europe’s flagship allergy and clinical immunology congress to showcase progress...
proactiveinvestors.com Amazon and Delta announce agreement to offer improved in-flight Wifi Amazon.com Inc (NASDAQ:AMZN) and Delta Air Lines Inc (NYSE:DAL) have announced a new multi-year agreement aimed at enhancing in-flight internet connectivity...
proactiveinvestors.com Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to...
proactiveinvestors.co.uk Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to self-sustaining profitability. That's according to…
proactiveinvestors.co.uk Allergy Therapeutics targets accelerating Grassmuno sales as peanut vaccine advances to next trial phase Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the immunotherapy company, expects commercial momentum to build through the second half of its financial year as its newly launched Grassmuno…
proactiveinvestors.com Dow set to jump as easing Middle East tensions lift Wall Street futures 8:15am: Cooling tensions US stocks were set for a strong open on Tuesday as easing geopolitical tensions lifted sentiment. Dow Jones and S&P 500 futures...
proactiveinvestors.com General Mills recovery likely multiyear, Jefferies says General Mills Inc (NYSE:GIS, XETRA:GRM) shares remain under pressure as it faces continued volume declines in North America Retail (NAR) and limited...
proactiveinvestors.co.uk Allergy Therapeutics peanut vaccine shows strong immune response in early trial AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed…
proactiveinvestors.com Allergy Therapeutics peanut vaccine shows strong immune response in early trial AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY,...
proactiveinvestors.co.uk Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed…
proactiveinvestors.com Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY,...
proactiveinvestors.com Lululemon price target slashed on outgoing CEO’s final day Jefferies analysts lowered their price target on Lululemon Athletica Inc (NASDAQ:LULU) stock to $185 from $200, coinciding with the outgoing CEO Calvin...
proactiveinvestors.com FTSE 100 Live: London stocks recover as markets await Fed chair nomination FTSE 100 gains 13 points to 10,185 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink 10.25am:...